ARLINGTON, Va. – National Association of Chain Drug Stores (NACDS) president and CEO Steven Anderson issued the following statement Tuesday:
“Words like ‘continuing resolution,’ ‘budget reconciliation,’ and ‘standalone bill’ are the words of Washington, DC. While all of these legislative vehicles are sorted out, one fact remains: pharmacy benefit manager (PBM) reform remains a long overdue need and the costs of inaction continue to ravage Americans, their pharmacies, and their communities.
“Every day, Americans are living with the acceleration of prescription drug price inflation and the closing of trusted and convenient pharmacies.At the hands of the PBM middlemen, nearly four pharmacies are closing each day – at an increasing rate. Americans have missed out on hundreds of millions of dollars of savings just since the last Congress ended. The costs of inaction on PBM reform are massive and they are growing, all while the PBMs redouble their revenue.
"Meanwhile, Congress has reforms ready to go – a sound package that was finalized last December. Americans need this win and it is time to deliver it to them. As Congress and the Administration figure out the legislative roadmap, PBM reform needs to get done without further needless delay.”
More information is available on a new NACDS fact sheet.
NACDS: A legislative vehicle must include PBM reform; inaction is costing Americans
Nearly four pharmacies are closing every day; Americans are missing out on hundreds of millions in savings just since the last Congress' end.
Related
Legendary General David Petraeus to headline 2026 NACDS Total Store Expo Business Program
Retired four-star general and former CIA Director to deliver strategic leadership insights at the industry's premier health, wellness, and consumer goods event.
Dupixent demonstrates improved esophageal function in eosinophilic esophagitis (EoE) Phase 4 trial
These results reinforce the roles of IL-4 and IL-13, two of the key and central drivers of type 2 inflammation, in EoE.
Cardinal Health, Shine Technologies amp up domestic production of radio-pharmaceuticals
Announcements from both are in line with a federal push for US-produced drugs.
Lilly’s Omvoh demonstrates durable disease clearance in ulcerative colitis through four years
In LUCENT-3, more than 60% of patients who achieved disease clearance at one year maintained it after four years of continuous Omvoh treatment.
Latest
Molson Canadian thanks Buffalo Sabers fans with a billboard as part of its “Cheer Canadian” campaign
Molson Canadian brings “Cheer Canadian” to Buffalo, celebrating fans who united for the Canadian anthem.
Lupin gets U.S. FDA approval for Glycerol Phenylbutyrate Oral Liquid
Glycerol Phenylbutyrate Oral Liquid, 1.1 grams per mL, is bioequivalent to the reference listed drug (RLD), Ravicti® Oral Liquid, 1.1 grams per mL, of Horizon Therapeutics U.S. Holding LLC.
Aetna and Goodr partner on mobile food market and chronic care initiative
Aetna Better Health of Louisiana, part of CVS Health, is teaming up with Goodr to launch a mobile food market and nutrition education program to tackle food insecurity and improve chronic disease outcomes statewide.
Gabrielle Union flashes drugstore lashes at the 2026 Met Gala
The falsies created a look that felt both soft and dramatically refined.